BioSig Technologies, Inc. (BSGM)

NASDAQ: BSGM · Real-Time Price · USD
4.290
-0.330 (-7.14%)
At close: Aug 1, 2025, 4:00 PM
4.440
+0.150 (3.50%)
After-hours: Aug 1, 2025, 7:36 PM EDT
-7.14%
Market Cap132.10M
Revenue (ttm)26,000
Net Income (ttm)-9.79M
Shares Out 30.79M
EPS (ttm)-0.58
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume631,090
Open4.520
Previous Close4.620
Day's Range4.050 - 4.650
52-Week Range0.230 - 14.110
Beta1.72
AnalystsStrong Buy
Price Target10.00 (+133.1%)
Earnings DateAug 13, 2025

About CTIC

BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale... [Read more]

Sector Healthcare
Founded 2009
Employees 5
Stock Exchange NASDAQ
Ticker Symbol BSGM
Full Company Profile

Financial Performance

In 2024, BioSig Technologies's revenue was $40,000, an increase of 122.22% compared to the previous year's $18,000. Losses were -$10.51 million, -63.81% less than in 2023.

Financial Statements

Analyst Summary

According to one analyst, the rating for BSGM stock is "Strong Buy" and the 12-month stock price target is $10.0.

Price Target
$10.0
(133.10% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

CORRECTION: BioSig & Streamex Clarify and Correct Details of Russell Starr's Appointment and Biography

VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM),...

18 days ago - Business Wire

BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations

LOS ANGELES & VANCOUVER, British Columbia--(BUSINESS WIRE)--BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig”), which recently merged with Streamex Exchange Corporation (“Streamex”) (together, “BSGM”...

18 days ago - Business Wire

CORRECTING and REPLACING BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor

VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--Please replace the release dated July 11, 2025 with the following corrected version due to revisions to details of Russell Starr's appointme...

18 days ago - Business Wire

BioSig & Streamex Appoint Defi Expert and Visionary, Russell Starr as Strategic Advisor

VANCOUVER, British Columbia & LOS ANGELES--(BUSINESS WIRE)--BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM),...

21 days ago - Business Wire

BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors

Los Angeles, CA & Vancouver, BC, June 09, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“St...

7 weeks ago - GlobeNewsWire

BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor

Los Angeles, CA and Vancouver, BC, June 04, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig”), which acquired Streamex Exchange Corporation as its wholly owned subsidiary (“...

2 months ago - GlobeNewsWire

BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Bio...

2 months ago - Business Wire

CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)

Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the ...

2 months ago - GlobeNewsWire

BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer

Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the “combined company”), which today acquired Streamex Exchange Corporation (“...

2 months ago - GlobeNewsWire

BioSig Enters into an LOI to Merge with Streamex Exchange Corp.

Los Angeles, May 05, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company is pleased to announce it has entered into a Letter of ...

3 months ago - GlobeNewsWire

BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market

Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-...

4 months ago - GlobeNewsWire

BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Los Angeles, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “Company"), a medical technology company delivering unprecedented accuracy and precision to int...

9 months ago - GlobeNewsWire

BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

Los Angeles, CA, Oct. 22, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to ...

10 months ago - GlobeNewsWire

BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation

Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-ca...

1 year ago - GlobeNewsWire

BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024

Los Angeles, CA 90025, July 25, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) or (“BioSig” or "Company"), a medical technology company delivering unprecedented accuracy and precisio...

1 year ago - GlobeNewsWire

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer

Westport, CT, June 10, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "Company"), a medical technology company delivering unprecedented accuracy and precision to int...

1 year ago - GlobeNewsWire

BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Westport, CT, May 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and prec...

1 year ago - GlobeNewsWire

BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

Westport, CT, May 21, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-c...

1 year ago - GlobeNewsWire

BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent

Westport, CT, May 03, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "the Company"), a medical technology company delivering unprecedented accuracy and precision to ...

1 year ago - GlobeNewsWire

BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

Westport, CT, April 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "the Company"), a medical technology Company delivering unprecedented accuracy and precision t...

1 year ago - GlobeNewsWire

BioSig Engages Consulting Firm for Business Model Strategies

BAIPC will work to deploy a series of solutions to transform BioSig's future course BAIPC will work to deploy a series of solutions to transform BioSig's future course

1 year ago - GlobeNewsWire

BioSig Announces Reduction of its Workforce

Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a signific...

1 year ago - GlobeNewsWire

BioSig's PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases

Company sees clinical adoption and usage of its novel Near Field Tracking algorithm, proven to reduce ablation time by approximately 66%. Company sees clinical adoption and usage of its novel Near Fie...

1 year ago - GlobeNewsWire

BioSig Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on February 2, 2024 Common Stock Will Begin Trading on Split-Adjusted Basis on February 2, 2024

1 year ago - GlobeNewsWire

BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy

Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) --   BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and ...

1 year ago - GlobeNewsWire